2015 Q1 Form 10-K Financial Statement
#000114420415020255 Filed on March 31, 2015
Income Statement
| Concept | 2015 Q1 | 2014 | 2013 Q4 |
|---|---|---|---|
| Revenue | $184.9K | $416.0K | |
| YoY Change | 49207.2% | 24661.67% | |
| Cost Of Revenue | $76.43K | $213.8K | |
| YoY Change | 127286.67% | 102704.81% | |
| Gross Profit | $108.5K | $202.2K | |
| YoY Change | 34334.92% | 13633.83% | |
| Gross Profit Margin | 58.66% | 48.6% | |
| Selling, General & Admin | $1.330M | $3.694M | |
| YoY Change | 43.01% | 16.9% | |
| % of Gross Profit | 1226.15% | 1827.27% | |
| Research & Development | $406.9K | $1.431M | |
| YoY Change | -17.6% | -10.25% | |
| % of Gross Profit | 375.09% | 707.66% | |
| Depreciation & Amortization | $39.61K | $96.69K | |
| YoY Change | 55.24% | -7.75% | |
| % of Gross Profit | 36.52% | 47.83% | |
| Operating Expenses | $1.734M | $5.125M | |
| YoY Change | 21.4% | 7.8% | |
| Operating Profit | -$1.626M | -$4.923M | |
| YoY Change | 13.83% | 3.58% | |
| Interest Expense | $64.64K | $285.3K | |
| YoY Change | -11.61% | -23.16% | |
| % of Operating Profit | |||
| Other Income/Expense, Net | -$134.2K | -$665.1K | |
| YoY Change | -44.39% | -33.42% | |
| Pretax Income | -$1.760M | -$5.224M | |
| YoY Change | 5.39% | -1.97% | |
| Income Tax | $0.00 | $0.00 | |
| % Of Pretax Income | |||
| Net Earnings | -$1.760M | -$5.588M | |
| YoY Change | 5.42% | -2.84% | |
| Net Earnings / Revenue | -951.92% | -1343.19% | |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$1.000M | -$4.376M | |
| COMMON SHARES | |||
| Basic Shares Outstanding | 37.15M shares | ||
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2015 Q1 | 2014 | 2013 Q4 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $150.0K | $91.80K | |
| YoY Change | 36.36% | -54.1% | |
| Cash & Equivalents | |||
| Short-Term Investments | |||
| Other Short-Term Assets | $30.00K | $20.57K | |
| YoY Change | 200.0% | 2.85% | |
| Inventory | $1.927K | $1.950K | $17.97K |
| Prepaid Expenses | |||
| Receivables | $0.00 | $0.00 | |
| Other Receivables | $0.00 | $0.00 | |
| Total Short-Term Assets | $180.2K | $114.3K | $239.8K |
| YoY Change | 31.25% | -52.37% | 666.63% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $537.2K | $493.9K | $35.57K |
| YoY Change | 2005.25% | 1134.65% | -40.13% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | $1.095M | $1.108M | |
| YoY Change | 0.44% | -5.93% | |
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $50.00K | $45.90K | |
| YoY Change | |||
| Total Long-Term Assets | $1.678M | $1.577M | $1.143M |
| YoY Change | 50.41% | 38.38% | -7.57% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $180.2K | $114.3K | $239.8K |
| Total Long-Term Assets | $1.678M | $1.577M | $1.143M |
| Total Assets | $1.858M | $1.692M | $1.383M |
| YoY Change | 48.31% | 22.59% | 9.06% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $1.266M | $1.112M | $1.270M |
| YoY Change | 5.19% | -12.45% | 64.63% |
| Accrued Expenses | $1.885M | $1.561M | $1.177M |
| YoY Change | 46.45% | 25.85% | 19.07% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | |
| YoY Change | |||
| Long-Term Debt Due | $5.460M | $5.688M | |
| YoY Change | 5.2% | 13.99% | |
| Total Short-Term Liabilities | $8.922M | $8.525M | $7.503M |
| YoY Change | 12.56% | 13.67% | 166.43% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $310.0K | $50.00K | |
| YoY Change | 10.71% | -90.38% | |
| Other Long-Term Liabilities | $20.00K | $5.200K | |
| YoY Change | -33.33% | -87.0% | |
| Total Long-Term Liabilities | $330.0K | $55.20K | |
| YoY Change | 6.45% | -90.14% | |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $8.922M | $8.525M | $7.503M |
| Total Long-Term Liabilities | $330.0K | $55.20K | |
| Total Liabilities | $9.250M | $8.580M | $8.068M |
| YoY Change | 12.31% | 6.32% | 25.87% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$27.16M | -$19.81M | |
| YoY Change | |||
| Common Stock | $19.63K | ||
| YoY Change | 27.13% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | $32.00K | ||
| YoY Change | 0.0% | ||
| Treasury Stock Shares | 558.6K shares | 558.6K shares | |
| Shareholders Equity | -$7.400M | -$6.888M | -$6.685M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $1.860M | $1.692M | $1.383M |
| YoY Change | 48.45% | 22.59% | 9.06% |
Cashflow Statement
| Concept | 2015 Q1 | 2014 | 2013 Q4 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$1.760M | -$5.588M | |
| YoY Change | 5.42% | -2.84% | |
| Depreciation, Depletion And Amortization | $39.61K | $96.69K | |
| YoY Change | 55.24% | -7.75% | |
| Cash From Operating Activities | -$670.0K | -$3.228M | |
| YoY Change | -16.95% | 20.78% | |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $92.17K | $168.4K | |
| YoY Change | 1408.75% | ||
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | -$80.00K | $980.00 | |
| YoY Change | |||
| Cash From Investing Activities | -$170.0K | -$167.4K | |
| YoY Change | -17446.94% | 1400.0% | |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 900.0K | 3.286M | |
| YoY Change | 25.87% | 13.93% | |
| NET CHANGE | |||
| Cash From Operating Activities | -670.0K | -3.228M | |
| Cash From Investing Activities | -170.0K | -167.4K | |
| Cash From Financing Activities | 900.0K | 3.286M | |
| Net Change In Cash | 60.00K | -109.3K | |
| YoY Change | -166.12% | -154.45% | |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$670.0K | -$3.228M | |
| Capital Expenditures | $92.17K | $168.4K | |
| Free Cash Flow | -$762.2K | -$3.396M | |
| YoY Change | -5.52% | 26.56% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2014 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>Use of Estimates</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif"> The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at dates of the financial statements and the reported amounts of revenue and expenses during the periods. The Company’s significant estimates and assumptions include the recoverability and useful lives of long-lived assets, the fair value of the Company’s equity securities and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates, including the carrying amount of the intangible assets, could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2014 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <u><font style="FONT-SIZE: 10pt">Reclassifications</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Certain prior period amounts have been reclassified for comparative purposes to conform to the fiscal 2014 presentation. These reclassifications have no impact on the previously reported net loss.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2013 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1594054 | USD |
| CY2014 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1430614 | USD |
| CY2014 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>Concentrations and Credit Risk</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif"> As of December 31, 2014, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 75</font>% of the face value of the Company’s outstanding notes payable were sourced from a single entity (the “Bermuda Lender”) and the maturity dates associated with these notes range from May 7, 2015 to June 30, 2015. See Note 7 – Notes Payable for additional discussion of the Bermuda Lender.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif"> Two pharmaceutical clients comprised substantially all of the Company’s revenue during the year ended December 31, 2014. See Revenue Recognition – Research and Development Agreements below. </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2014Q4 | us-gaap |
Cash
Cash
|
91798 | USD |
| CY2014Q4 | us-gaap |
Inventory Net
InventoryNet
|
1945 | USD |
| CY2014Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
20570 | USD |
| CY2014Q4 | us-gaap |
Assets Current
AssetsCurrent
|
114313 | USD |
| CY2014Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
493856 | USD |
| CY2014Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
1037732 | USD |
| CY2014Q4 | us-gaap |
Assets
Assets
|
1691801 | USD |
| CY2014Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1111879 | USD |
| CY2014Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1466506 | USD |
| CY2013Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
65909 | USD |
| CY2014Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
94026 | USD |
| CY2013Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
4990009 | USD |
| CY2014Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
5688239 | USD |
| CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
7502550 | USD |
| CY2014Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
8524999 | USD |
| CY2013Q4 | us-gaap |
Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
|
41434 | USD |
| CY2014Q4 | us-gaap |
Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
|
5195 | USD |
| CY2013Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
524000 | USD |
| CY2013Q4 | us-gaap |
Liabilities
Liabilities
|
8067984 | USD |
| CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
19633 | USD |
| CY2013Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
13139712 | USD |
| CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-19812414 | USD |
| CY2014Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-25400026 | USD |
| CY2013Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
32000 | USD |
| CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-6685069 | USD |
| CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1382915 | USD |
| CY2013 | us-gaap |
Advertising Expense
AdvertisingExpense
|
25748 | USD |
| CY2014 | us-gaap |
Advertising Expense
AdvertisingExpense
|
15280 | USD |
| CY2013Q2 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
the Company implemented a 1-for-50 reverse split | |
| CY2013Q2 | us-gaap |
Stockholders Equity Note Changes In Capital Structure Retroactive Impact
StockholdersEquityNoteChangesInCapitalStructureRetroactiveImpact
|
1,500,000,000 to 100,000,000 | |
| CY2013Q2 | brtx |
Stockholders Equity Note Changes In Capital Structure Retroactive Impact Shares
StockholdersEquityNoteChangesInCapitalStructureRetroactiveImpactShares
|
1500000000 | shares |
| CY2013Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
| CY2014Q4 | brtx |
Working Capital Net
WorkingCapitalNet
|
8410686 | USD |
| CY2014Q4 | brtx |
Debt Instrument Outstanding Face Amount Percentage
DebtInstrumentOutstandingFaceAmountPercentage
|
0.75 | pure |
| CY2013Q4 | brtx |
Office Equipment Gross
OfficeEquipmentGross
|
7670 | USD |
| CY2014Q4 | brtx |
Office Equipment Gross
OfficeEquipmentGross
|
8466 | USD |
| CY2013Q4 | brtx |
Medical Equipment Gross
MedicalEquipmentGross
|
129461 | USD |
| CY2014Q4 | brtx |
Medical Equipment Gross
MedicalEquipmentGross
|
359248 | USD |
| CY2013Q4 | us-gaap |
Furniture And Fixtures Gross
FurnitureAndFixturesGross
|
19322 | USD |
| CY2014Q4 | us-gaap |
Furniture And Fixtures Gross
FurnitureAndFixturesGross
|
113874 | USD |
| CY2013Q4 | brtx |
Debt Instrument Unamortized Debt Discount Current Portion
DebtInstrumentUnamortizedDebtDiscountCurrentPortion
|
237381 | USD |
| CY2014Q4 | brtx |
Debt Instrument Unamortized Debt Discount Current Portion
DebtInstrumentUnamortizedDebtDiscountCurrentPortion
|
113257 | USD |
| CY2013Q4 | brtx |
Debt Instrument Unamortized Debt Discount Noncurrent Portion
DebtInstrumentUnamortizedDebtDiscountNoncurrentPortion
|
3110 | USD |
| CY2014Q4 | brtx |
Debt Instrument Unamortized Debt Discount Noncurrent Portion
DebtInstrumentUnamortizedDebtDiscountNoncurrentPortion
|
0 | USD |
| CY2013Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2014Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2014Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
19633173 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
34511800 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
19074552 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
33953179 | shares |
| CY2013Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
558621 | shares |
| CY2014Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
558621 | shares |
| CY2013 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
10902270 | shares |
| CY2014 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
24486568 | shares |
| CY2013 | us-gaap |
Depreciation
Depreciation
|
34999 | USD |
| CY2014 | us-gaap |
Depreciation
Depreciation
|
26872 | USD |
| CY2013Q4 | us-gaap |
Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
|
20169 | USD |
| CY2014Q4 | us-gaap |
Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
|
66458 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
176622 | USD |
| CY2014Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
651628 | USD |
| CY2013Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
141054 | USD |
| CY2014Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
157772 | USD |
| CY2012Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
1000000 | USD |
| CY2012Q2 | us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P17Y8M12D | |
| CY2014 | brtx |
Finite Lived Intangible Asset Useful Life From Application Date
FiniteLivedIntangibleAssetUsefulLifeFromApplicationDate
|
P2Y3M18D | |
| CY2014 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
70000 | USD |
| CY2012Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
1177357 | USD |
| CY2013 | brtx |
Intangible Assets Amortization Expense
IntangibleAssetsAmortizationExpense
|
69812 | USD |
| CY2014 | brtx |
Intangible Assets Amortization Expense
IntangibleAssetsAmortizationExpense
|
69813 | USD |
| CY2013 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
144285 | USD |
| CY2014 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
58054 | USD |
| CY2013 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
119295 | USD |
| CY2014 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
83044 | USD |
| CY2013Q4 | us-gaap |
Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
|
24990 | USD |
| CY2013Q4 | brtx |
Credit Card Payable Current
CreditCardPayableCurrent
|
6000 | USD |
| CY2014Q4 | brtx |
Credit Card Payable Current
CreditCardPayableCurrent
|
4739 | USD |
| CY2013Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
672535 | USD |
| CY2014Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
679277 | USD |
| CY2013Q4 | us-gaap |
Accrued Rent Current
AccruedRentCurrent
|
2310 | USD |
| CY2014Q4 | us-gaap |
Accrued Rent Current
AccruedRentCurrent
|
0 | USD |
| CY2014Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
83333 | USD |
| CY2014Q3 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
4000000 | USD |
| CY2014Q4 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
7500 | USD |
| CY2014Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
108059 | USD |
| CY2014Q3 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
550000 | shares |
| CY2013Q4 | brtx |
Common Stock Aggregate Grant Date Fair Value
CommonStockAggregateGrantDateFairValue
|
3704 | USD |
| CY2014Q4 | brtx |
Common Stock Aggregate Grant Date Fair Value
CommonStockAggregateGrantDateFairValue
|
74029 | USD |
| CY2013 | brtx |
Warrant Issued During Period Relative Fair Value
WarrantIssuedDuringPeriodRelativeFairValue
|
112239 | USD |
| CY2013Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
402500 | shares |
| CY2014Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
190000 | shares |
| CY2014 | us-gaap |
Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
|
15000 | USD |
| CY2014 | us-gaap |
Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
|
175000 | USD |
| CY2014 | us-gaap |
Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
|
92370 | USD |
| CY2014 | us-gaap |
Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
|
0.15 | pure |
| CY2014 | brtx |
Note Payable Principal Issued
NotePayablePrincipalIssued
|
800000 | USD |
| CY2013 | brtx |
Conversion Of Accrued Interest
ConversionOfAccruedInterest
|
68100 | USD |
| CY2014Q4 | us-gaap |
Notes Payable
NotesPayable
|
5738239 | USD |
| CY2013 | us-gaap |
Revenues
Revenues
|
1680 | USD |
| CY2014 | us-gaap |
Revenues
Revenues
|
415996 | USD |
| CY2013 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
208 | USD |
| CY2014 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
213834 | USD |
| CY2013 | us-gaap |
Gross Profit
GrossProfit
|
1472 | USD |
| CY2014 | us-gaap |
Gross Profit
GrossProfit
|
202162 | USD |
| CY2014 | us-gaap |
Payments For Royalties
PaymentsForRoyalties
|
100000 | USD |
| CY2012Q4 | us-gaap |
Notes Payable
NotesPayable
|
4555466 | USD |
| CY2013 | brtx |
Note Payable Principal Issued
NotePayablePrincipalIssued
|
1464000 | USD |
| CY2013 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
114951 | USD |
| CY2014 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
125626 | USD |
| CY2013 | us-gaap |
Professional Fees
ProfessionalFees
|
779462 | USD |
| CY2014 | us-gaap |
Professional Fees
ProfessionalFees
|
1310121 | USD |
| CY2013 | brtx |
Exchanges For Equity
ExchangesForEquity
|
-404285 | USD |
| CY2014 | brtx |
Exchanges For Equity
ExchangesForEquity
|
-274000 | USD |
| CY2013 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
5500 | USD |
| CY2014 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
202063 | USD |
| CY2013 | brtx |
Set Up Of Debt Discount
SetUpOfDebtDiscount
|
-574369 | USD |
| CY2014 | brtx |
Set Up Of Debt Discount
SetUpOfDebtDiscount
|
-347170 | USD |
| CY2013 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
405531 | USD |
| CY2014 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
464470 | USD |
| CY2013 | brtx |
Accretion Of Interest Expense
AccretionOfInterestExpense
|
5066 | USD |
| CY2014 | brtx |
Accretion Of Interest Expense
AccretionOfInterestExpense
|
24934 | USD |
| CY2013Q4 | us-gaap |
Notes Payable
NotesPayable
|
5514009 | USD |
| CY2013 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2265275 | USD |
| CY2014 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2258307 | USD |
| CY2013 | us-gaap |
Operating Expenses
OperatingExpenses
|
4753742 | USD |
| CY2014 | us-gaap |
Operating Expenses
OperatingExpenses
|
5124668 | USD |
| CY2013 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4752270 | USD |
| CY2014 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4922506 | USD |
| CY2013 | us-gaap |
Interest Expense
InterestExpense
|
371281 | USD |
| CY2014 | us-gaap |
Interest Expense
InterestExpense
|
285275 | USD |
| CY2013 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-7200 | USD |
| CY2014 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-49094 | USD |
| CY2013 | brtx |
Warrant Modification Expense
WarrantModificationExpense
|
214912 | USD |
| CY2014 | brtx |
Warrant Modification Expense
WarrantModificationExpense
|
50035 | USD |
| CY2013 | brtx |
Gain Loss Related To Settlement Of Note And Payables
GainLossRelatedToSettlementOfNoteAndPayables
|
0 | USD |
| CY2014 | brtx |
Gain Loss Related To Settlement Of Note And Payables
GainLossRelatedToSettlementOfNoteAndPayables
|
183768 | USD |
| CY2013 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-998924 | USD |
| CY2014 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-665106 | USD |
| CY2013 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5751194 | USD |
| CY2014 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5587612 | USD |
| CY2013 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.35 | |
| CY2014 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.22 | |
| CY2013 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
16526793 | shares |
| CY2014 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
25538075 | shares |
| CY2013Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
14000000 | USD |
| CY2014Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
12700000 | USD |
| CY2014 | brtx |
Operating Loss Carry Forwards Expiration Period
OperatingLossCarryForwardsExpirationPeriod
|
The net operating loss carry forwards, if not utilized, will expire from 2029 to 2034 for federal purposes. | |
| CY2014Q4 | brtx |
Percentage Of Ownership Changes
PercentageOfOwnershipChanges
|
0.5 | pure |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
5327000 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
4820500 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
907100 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
1272600 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
|
139800 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
|
240700 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
6376600 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
6431400 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
|
93200 | USD |
| CY2013Q4 | brtx |
Deferred Tax Liabilities Fixed Asset Depreciation
DeferredTaxLiabilitiesFixedAssetDepreciation
|
3000 | USD |
| CY2014Q4 | brtx |
Deferred Tax Liabilities Fixed Asset Depreciation
DeferredTaxLiabilitiesFixedAssetDepreciation
|
8100 | USD |
| CY2013Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
3000 | USD |
| CY2014Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
101300 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
6373600 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
6330100 | USD |
| CY2013 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-171716 | USD |
| CY2014 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
4579 | USD |
| CY2013 | brtx |
Income Tax Expense Benefit Continuing Operations Before Change In Valuation Allowance
IncomeTaxExpenseBenefitContinuingOperationsBeforeChangeInValuationAllowance
|
-1631300 | USD |
| CY2014 | brtx |
Income Tax Expense Benefit Continuing Operations Before Change In Valuation Allowance
IncomeTaxExpenseBenefitContinuingOperationsBeforeChangeInValuationAllowance
|
43500 | USD |
| CY2013 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2014 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
-0.340 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
-0.340 | pure |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
6373600 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
6330100 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
| CY2013 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
1631300 | USD |
| CY2014 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
-43500 | USD |
| CY2013 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
| CY2014 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
| CY2013 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-1459584 | USD |
| CY2014 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
38921 | USD |
| CY2013 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | USD |
| CY2014 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | USD |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.040 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.040 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.058 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.008 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
|
0.016 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
|
-0.014 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.306 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.008 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.0 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.0 | pure |
| CY2014Q1 | brtx |
Share Based Compensation Arrangement By Share Based Payment Award Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantDateFairValue
|
67830 | USD |
| CY2014Q4 | brtx |
Share Based Compensation Arrangement By Share Based Payment Award Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantDateFairValue
|
15000 | USD |
| CY2014Q4 | brtx |
Share Based Compensation Arrangement By Share Based Payment Award Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantDateFairValue
|
124200 | USD |
| CY2014Q1 | brtx |
Warrant To Purchase Common Stock Issued In Period Contractual Term
WarrantToPurchaseCommonStockIssuedInPeriodContractualTerm
|
P3Y | |
| CY2011Q1 | us-gaap |
Lease Expiration Date1
LeaseExpirationDate1
|
2014-01-31 | |
| CY2014Q4 | brtx |
Lease Rent Second Year
LeaseRentSecondYear
|
6234 | USD |
| CY2014Q4 | brtx |
Lease Rent Third Year
LeaseRentThirdYear
|
6422 | USD |
| CY2013Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
|
353000 | USD |
| CY2014Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
|
43000 | USD |
| CY2014Q4 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
48388 | USD |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
500000 | shares |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.32 | |
| CY2014Q4 | brtx |
Salaries And Wages Initial Year
SalariesAndWagesInitialYear
|
25000 | USD |
| CY2014Q4 | brtx |
Percentage Of Increase Salary
PercentageOfIncreaseSalary
|
0.28 | pure |
| CY2013Q4 | us-gaap |
Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
|
542535 | USD |
| CY2014Q4 | us-gaap |
Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
|
574278 | USD |
| CY2013 | us-gaap |
Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
|
565000 | USD |
| CY2013Q4 | us-gaap |
Loss Contingency Damages Paid Value
LossContingencyDamagesPaidValue
|
193000 | USD |
| CY2013Q4 | brtx |
Loss Contingency Damages Paid Value Warrants Issued
LossContingencyDamagesPaidValueWarrantsIssued
|
80000 | shares |
| CY2013 | brtx |
Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
|
905000 | USD |
| CY2014 | brtx |
Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
|
2605000 | USD |
| CY2013Q4 | brtx |
Warrant To Purchase Common Stock Issued In Period
WarrantToPurchaseCommonStockIssuedInPeriod
|
403590 | shares |
| CY2014Q4 | brtx |
Warrant To Purchase Common Stock Issued In Period
WarrantToPurchaseCommonStockIssuedInPeriod
|
2330693 | shares |
| CY2013Q4 | brtx |
Warrants Aggregate Grant Date Fair Value
WarrantsAggregateGrantDateFairValue
|
224313 | USD |
| CY2014Q4 | brtx |
Warrants Aggregate Grant Date Fair Value
WarrantsAggregateGrantDateFairValue
|
389608 | USD |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
|
831669 | shares |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
|
490000 | shares |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0.26 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0.27 | |
| CY2014Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
20000000 | shares |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
| CY2013 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
505809 | USD |
| CY2014 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
113000 | USD |
| CY2013 | brtx |
Warrant Modification Charge
WarrantModificationCharge
|
214912 | USD |
| CY2014 | brtx |
Warrant Modification Charge
WarrantModificationCharge
|
50035 | USD |
| CY2013Q4 | brtx |
Warrant Redemption Terms
WarrantRedemptionTerms
|
The terms of the newly issued warrant permit the Company to redeem the new warrant for a total of $1.00 if the common stock of the Company trades above $1.25 for five consecutive trading days. | |
| CY2014Q4 | brtx |
Share Based Compensation Exercise Price Range Number Of Outstanding Warrants
ShareBasedCompensationExercisePriceRangeNumberOfOutstandingWarrants
|
8248683 | shares |
| CY2014 | brtx |
Share Based Compensations Exercise Price Range Exercisable Warrant Weighted Average Remaining Contractual Term
ShareBasedCompensationsExercisePriceRangeExercisableWarrantWeightedAverageRemainingContractualTerm
|
P3Y3M18D | |
| CY2014Q4 | brtx |
Share Based Compensation Exercise Price Range Number Of Exercisable Warrants
ShareBasedCompensationExercisePriceRangeNumberOfExercisableWarrants
|
7548683 | shares |
| CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-5141693 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
140000 | USD |
| CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
674592 | USD |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4018000 | shares |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
1145000 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
10575000 | shares |
| CY2013 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares |
| CY2014 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
120000 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
34000 | shares |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
5043000 | shares |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
15584000 | shares |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
6371502 | shares |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.12 | |
| CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.68 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.41 | |
| CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
0.50 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
1.31 | |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.03 | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.61 | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
0.91 | |
| CY2014 | brtx |
Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y6M | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P7Y7M6D | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
979600 | USD |
| CY2014Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
45600 | USD |
| CY2014 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2014 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
| CY2014 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2014 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2014 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
| CY2014Q2 | dei |
Entity Public Float
EntityPublicFloat
|
5692745 | USD |
| CY2014 | dei |
Trading Symbol
TradingSymbol
|
BRTX | |
| CY2015Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
37149052 | shares |
| CY2013Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
164349 | USD |
| CY2014Q4 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
|
15584000 | shares |
| CY2014 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
|
P7Y7M6D | |
| CY2014Q4 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
|
6371502 | shares |
| CY2015Q1 | brtx |
Warrants Issued During Period Number Of Warrants
WarrantsIssuedDuringPeriodNumberOfWarrants
|
100000 | shares |
| CY2015Q1 | brtx |
Warrants Issued During Period Exercise Price
WarrantsIssuedDuringPeriodExercisePrice
|
0.47 | |
| CY2013 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
104811 | USD |
| CY2014 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
96685 | USD |
| CY2013 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
0 | USD |
| CY2014 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-1009 | USD |
| CY2013 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
812647 | USD |
| CY2014 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1360296 | USD |
| CY2013 | brtx |
Warrant Issued In Connection With Note Payable
WarrantIssuedInConnectionWithNotePayable
|
9400 | USD |
| CY2014 | brtx |
Warrant Issued In Connection With Note Payable
WarrantIssuedInConnectionWithNotePayable
|
0 | USD |
| CY2013 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
5481 | USD |
| CY2014 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-613 | USD |
| CY2013 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
2306 | USD |
| CY2014 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-11219 | USD |
| CY2013 | us-gaap |
Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
|
0 | USD |
| CY2014 | us-gaap |
Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
|
45900 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
498541 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-234563 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
1028469 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
585881 | USD |
| CY2013 | us-gaap |
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
|
3078790 | USD |
| CY2014 | us-gaap |
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
|
2359761 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-2672404 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-3227851 | USD |
| CY2013 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
11160 | USD |
| CY2014 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
168376 | USD |
| CY2013 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
0 | USD |
| CY2014 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
980 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-11160 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-167396 | USD |
| CY2013 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
1454000 | USD |
| CY2014 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
795000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
2884299 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
3285947 | USD |
| CY2013 | us-gaap |
Cash Period Increase Decrease
CashPeriodIncreaseDecrease
|
200735 | USD |
| CY2014 | us-gaap |
Cash Period Increase Decrease
CashPeriodIncreaseDecrease
|
-109300 | USD |
| CY2012Q4 | us-gaap |
Cash
Cash
|
363 | USD |
| CY2013 | us-gaap |
Interest Paid
InterestPaid
|
62346 | USD |
| CY2014 | us-gaap |
Interest Paid
InterestPaid
|
127112 | USD |
| CY2013 | brtx |
Reclassification Of Accrued Interest In Connection With Note Payable Issuance
ReclassificationOfAccruedInterestInConnectionWithNotePayableIssuance
|
68100 | USD |
| CY2014 | brtx |
Reclassification Of Accrued Interest In Connection With Note Payable Issuance
ReclassificationOfAccruedInterestInConnectionWithNotePayableIssuance
|
108059 | USD |
| CY2013 | brtx |
Waiver Of Previously Accrued Executive Salary And Bonus
WaiverOfPreviouslyAccruedExecutiveSalaryAndBonus
|
565000 | USD |
| CY2014 | brtx |
Waiver Of Previously Accrued Executive Salary And Bonus
WaiverOfPreviouslyAccruedExecutiveSalaryAndBonus
|
0 | USD |
| CY2014 | dei |
Document Type
DocumentType
|
10-K | |
| CY2014 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2014 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2014-12-31 | |
| CY2014 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | |
| CY2014 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
| CY2014 | dei |
Entity Registrant Name
EntityRegistrantName
|
BioRestorative Therapies, Inc. | |
| CY2014 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001505497 | |
| CY2014 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-5223749 | USD |
| CY2013Q4 | us-gaap |
Security Deposit
SecurityDeposit
|
0 | USD |
| CY2014Q4 | us-gaap |
Security Deposit
SecurityDeposit
|
45900 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
359711 | USD |
| CY2013 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
0 | USD |
| CY2014 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
164349 | USD |
| CY2013Q4 | us-gaap |
Leasehold Improvements Gross
LeaseholdImprovementsGross
|
0 | USD |
| CY2014Q4 | us-gaap |
Leasehold Improvements Gross
LeaseholdImprovementsGross
|
103582 | USD |
| CY2013 | us-gaap |
Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
|
0 | USD |
| CY2013 | brtx |
Conversion Of Notes Payable And Accruedinterest In To Common Stock
ConversionOfNotesPayableAndAccruedinterestInToCommonStock
|
0 | USD |
| CY2014 | brtx |
Conversion Of Notes Payable And Accruedinterest In To Common Stock
ConversionOfNotesPayableAndAccruedinterestInToCommonStock
|
359711 | USD |
| CY2014 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
342500 | USD |
| CY2013 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
99175 | USD |
| CY2014 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
20380 | USD |
| CY2014Q4 | brtx |
Payments Under Research And Development Agreements
PaymentsUnderResearchAndDevelopmentAgreements
|
113000 | USD |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
11219 | shares |
| CY2014Q3 | brtx |
Monthly Payments Under Consulting Agreements
MonthlyPaymentsUnderConsultingAgreements
|
10000 | USD |
| CY2014 | brtx |
Settlement Of Accreted Interest
SettlementOfAccretedInterest
|
-7500 | USD |
| CY2014 | us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
30000 | USD |
| CY2014Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.75 | |
| CY2014 | us-gaap |
Debt Instrument Maturity Date Range Start1
DebtInstrumentMaturityDateRangeStart1
|
2014-12-31 | |
| CY2014Q3 | us-gaap |
Debt Instrument Maturity Date Range Start1
DebtInstrumentMaturityDateRangeStart1
|
2014-07-31 | |
| CY2014 | us-gaap |
Debt Instrument Maturity Date Range End1
DebtInstrumentMaturityDateRangeEnd1
|
2015-06-30 | |
| CY2014Q3 | us-gaap |
Debt Instrument Maturity Date Range End1
DebtInstrumentMaturityDateRangeEnd1
|
2014-12-31 | |
| CY2014Q3 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
121000 | USD |
| CY2014Q4 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
99000 | USD |
| CY2014Q1 | brtx |
Monthly Payments For Leasing
MonthlyPaymentsForLeasing
|
962 | USD |
| CY2014 | brtx |
Stock Issued During Period Value Issued In Exchange Of Notes Payable Principal Amount
StockIssuedDuringPeriodValueIssuedInExchangeOfNotesPayablePrincipalAmount
|
71000 | USD |
| CY2014 | brtx |
Stock Issued During Period Value Issued In Exchange Of Notes Payable Interest Amount
StockIssuedDuringPeriodValueIssuedInExchangeOfNotesPayableInterestAmount
|
4260 | USD |
| CY2014 | brtx |
Stock Issued During Period Shares Issued In Exchange Of Notes Payable
StockIssuedDuringPeriodSharesIssuedInExchangeOfNotesPayable
|
246764 | shares |
| CY2014Q4 | brtx |
Warrants Issued During Period Number Of Warrants1
WarrantsIssuedDuringPeriodNumberOfWarrants1
|
100000 | shares |
| CY2014Q4 | brtx |
Monthly Payments Under Consulting Agreements
MonthlyPaymentsUnderConsultingAgreements
|
15000 | USD |
| CY2014Q4 | brtx |
Monthly Escalating Payments Under Consulting Agreements
MonthlyEscalatingPaymentsUnderConsultingAgreements
|
10000 | USD |
| CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
565000 | USD |
| CY2013 | brtx |
Shares Issued In Satisfaction Of Accrued Interest
SharesIssuedInSatisfactionOfAccruedInterest
|
213000 | USD |
| CY2014Q3 | brtx |
Cash Proceeds From Research Agreements
CashProceedsFromResearchAgreements
|
89063 | USD |
| CY2013 | us-gaap |
Accretion Expense
AccretionExpense
|
5066 | USD |
| CY2014 | us-gaap |
Accretion Expense
AccretionExpense
|
24934 | USD |
| CY2013 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
0 | USD |
| CY2014 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
15407 | USD |
| CY2013 | brtx |
Accrued Purchases Of Property And Equipment
AccruedPurchasesOfPropertyAndEquipment
|
0 | USD |
| CY2014 | brtx |
Accrued Purchases Of Property And Equipment
AccruedPurchasesOfPropertyAndEquipment
|
258774 | USD |
| CY2013Q4 | brtx |
Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
|
229276 | USD |
| CY2014Q4 | brtx |
Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
|
292395 | USD |
| CY2013Q4 | brtx |
Accrued General And Administrative Expenses
AccruedGeneralAndAdministrativeExpenses
|
266541 | USD |
| CY2014Q4 | brtx |
Accrued General And Administrative Expenses
AccruedGeneralAndAdministrativeExpenses
|
315294 | USD |
| CY2014 | brtx |
Received Noninterest Bearing Advances From Officer
ReceivedNoninterestBearingAdvancesFromOfficer
|
60055 | USD |
| CY2014 | brtx |
Repayments Short Term Advances
RepaymentsShortTermAdvances
|
60055 | USD |
| CY2013Q4 | brtx |
Accrued Purchase Of Property And Equipment
AccruedPurchaseOfPropertyAndEquipment
|
0 | USD |
| CY2014Q4 | brtx |
Accrued Purchase Of Property And Equipment
AccruedPurchaseOfPropertyAndEquipment
|
174801 | USD |
| CY2014 | brtx |
Recharacterization Of Accrued Interest As Principal
RecharacterizationOfAccruedInterestAsPrincipal
|
108059 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
|
95500 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
2100 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
2700 | USD |
| CY2013 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-5328958 | USD |
| CY2014 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-363863 | USD |
| CY2013 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-422236 | USD |
| CY2014 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-5587612 | USD |
| CY2013 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-5751194 | USD |
| CY2014 | brtx |
Effective Income Tax Rate Reconciliation Tax Credits Research And Development
EffectiveIncomeTaxRateReconciliationTaxCreditsResearchAndDevelopment
|
-0.018 | pure |
| CY2013 | brtx |
Effective Income Tax Rate Reconciliation Tax Credits Research And Development
EffectiveIncomeTaxRateReconciliationTaxCreditsResearchAndDevelopment
|
0.0 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
|
0.412 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
|
0.0 | pure |
| CY2014 | brtx |
Description For Section382 Limitation One
DescriptionForSection382LimitationOne
|
approximately $5,700,000 of federal NOLs not being realizable | |
| CY2014 | brtx |
Description For Section382 Limitation Two
DescriptionForSection382LimitationTwo
|
the reversal of approximately $2,200,000 of net operating loss deferred tax assets. | |
| CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1059459 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
138055 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
300837 | USD |
| CY2015Q1 | us-gaap |
Severance Costs1
SeveranceCosts1
|
125000 | USD |
| CY2013Q4 | us-gaap |
Loss Contingency Allegations
LossContingencyAllegations
|
The action is associated with an alleged $5,000 loan made in 2009 and an alleged consulting/employment agreement entered into with the Company effective in 2009. | |
| CY2013Q4 | brtx |
Loss Contingency Damages Paid Value Per Year
LossContingencyDamagesPaidValuePerYear
|
52000 | USD |
